IAFF Launches Smoking Cessation Campaign with Pfizer

Pfizer Inc.The International Association of Fire Fighters has announced the launch of a new initiative to help fire fighters, family members and friends to quit smoking cigarettes. "Our goal is to help make the IAFF the first smoke-free union," IAFF General President Harold Schaitberger said in his address to delegates at the IAFF 49th Convention.

The IAFF is collaborating with pharmaceutical company Pfizer Inc. to promote smoking cessation. Schaitberger and Pfizer CEO Jeff Kindler first announced the joint initiative at the IAFF Health and Safety Conference in Chicago, Illinois, in October 2007.

The campaign includes materials designed to help fire fighters understand the risks of smoking and provide information on how to quit. These and other resources are available on a new web site at www.iaff.org/smokefree. In the coming weeks, the campaign will add new resources, including a DVD featuring stories from fire fighters about how they quit smoking. The web site and other materials are available to assist IAFF affiliates across North America in reaching out to members, families and communities to promote and encourage smoking cessation.

Smoking is a major health risk for fire fighters who are already at high risk for illnesses, including heart disease, respiratory disease and certain cancers. In addition, smoking is the leading cause of fires and a significant occupational risk for fire fighters.

"We congratulate the IAFF for its commitment to this campaign and look forward to working together toward the goal of a smoke-free union," Kindler said. "Fire fighters are respected leaders in their communities, and this program on smoking cessation reaffirms that leadership."

"Fire fighters place themselves in harm's way, confront dangerous environments, high heat and flames, and exposure to burning materials," Schaitberger said. "It's stressful work and some respond to stress by smoking. Yet smoking increases the health risks fire fighters face. We want to help prevent that."

The International Association of Fire Fighters, headquartered in Washington, DC, represents more than 288,000 full-time professional fire fighters and paramedics who protect 85 percent of the nation's population. More information is available at www.iaff.org.

Pfizer discovers and develops innovative medicines to treat and help prevent disease for both people and animals. We also partner with healthcare providers, governments and local communities around the world to expand access to our medicines and to provide better quality healthcare and health system support.

Most Popular Now

NextPoint Therapeutics announces $80 million Serie…

NextPoint Therapeutics, a biotechnology company developing a new world of precision immuno-oncology, announced today that it raised $80 million in Series B financing co-l...

AstraZeneca to acquire CinCor Pharma to strengthen…

AstraZeneca has entered into a definitive agreement to acquire CinCor Pharma, Inc. (CinCor), a US-based clinical-stage biopharmaceutical company, focused on developing no...

Time-restricted eating reshapes gene expression th…

Numerous studies have shown health benefits of time-restricted eating including increase in life span in laboratory studies, making practices like intermittent fasting a ...

Incurable liver disease may prove curable

Research led by Associate Professor Duc Dong, Ph.D., has shown for the first time that the effects of Alagille syndrome, an incurable genetic disorder that affects the li...

Scientists develop a cancer vaccine to simultaneou…

Scientists are harnessing a new way to turn cancer cells into potent, anti-cancer agents. In the latest work from the lab of Khalid Shah, MS, PhD, at Brigham and Women’s ...

Bayer to accelerate drug discovery with Google Clo…

Bayer AG and Google Cloud announced a collaboration to drive early drug discovery that will apply Google Cloud's Tensor Processing Units (TPUs), which are custom-develope...

Acquisition of Neogene Therapeutics completed

AstraZeneca has completed the acquisition of Neogene Therapeutics Inc. (Neogene), a global clinical-stage biotechnology company pioneering the discovery, development and ...

Study identifies potential new approach for treati…

Targeting iron metabolism in immune system cells may offer a new approach for treating systemic lupus erythematosus (SLE) - the most common form of the chronic autoimmune...

Nanotechnology may improve gene therapy for blindn…

Using nanotechnology that enabled mRNA-based COVID-19 vaccines, a new approach to gene therapy may improve how physicians treat inherited forms of blindness. A collabo...

Modified CRISPR-based enzymes improve the prospect…

Many genetic diseases are caused by diverse mutations spread across an entire gene, and designing genome editing approaches for each patient’s mutation would be impractic...

Pfizer expands 'An Accord for a Healthier World' p…

Pfizer Inc. (NYSE: PFE) announced that it has significantly expanded its commitment to An Accord for a Healthier World to offer the full portfolio of medicines and vaccin...

500,000 missed out on blood pressure lowering drug…

Nearly half a million people missed out on starting medication to lower their blood pressure during the COVID-19 pandemic, according to research supported by the British ...